InvestorsHub Logo
icon url

elMoose

08/31/19 12:50 AM

#94552 RE: frequent1 #94549

It may be sufficient and if not, the process can perhaps be repeated and the dilutions will be relatively small compared to the previous rounds and the predators can not sit on the stock and waiting for a dilution and steal the market cap. The marketcap will be less prone to predatory behavior because it will be protected by the partners. The partners will not act like scaredy cats.

As you can see the shorts don't have any sensible talking points that they can use to scare the longs. They have no scheduled doomsday clock for dilution. That game has ended.

icon url

gerkdogg

08/31/19 1:09 AM

#94554 RE: frequent1 #94549

It’s possible. Need the share price to get comfortably above warrant exercise prices and grab some of that money.

My guess is if that doesn’t happen, and they need cash and are getting close to the Aspire limit, they will find an “Aspire 2.0” to get in on another chuck of the $125M.

All the money is there. Not an issue anymore. Just need to keep pushing the rock. The closer we get to submittal, the higher the probability of a partner/buyout.
icon url

SPORT19

08/31/19 7:13 AM

#94558 RE: frequent1 #94549

No it will not. The company needs far more than $35m to get to FDA submission. It’s in the fillings.